Single-use connection technologies are expected to play a critical role in commercial manufacturing of cell and gene therapies. Join us for an industry panel discussion on the current challenges facing the development of cell and gene therapy technologies, and a discussion of ideas to inspire the future.
Learn how to help maintain the integrity of a drug substance and safeguard for your downstream processes.
Hosted by Todd Andrews, Global Sales and Business Development Manager – Bioprocessing
Sr. Business Development Manager CGT
FlexFactory Director of Business Development
GE Healthcare Life Sciences
Global Head of Cell Therapy
Originally recorded at BPI Boston 2019.
The presentation is about 21 minutes.
For more details view on solutions for Cell and Gene therapy here.